PI
ALXN

Placemark Investments’s Alexion Pharmaceuticals ALXN Stock Holding History

Placemark Investments’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$2.15M Sell
11,641
-54
-0.5% -$10K 0.04% 545
2014
Q3 		$1.94M Buy
11,695
+475
+4% +$78K 0.04% 564
2014
Q2 		$1.75M Buy
11,220
+2,169
+24% +$342K 0.03% 620
2014
Q1 		$1.38M Buy
9,051
+433
+5% +$68.8K 0.03% 669
2013
Q4 		$1.15M Buy
8,618
+521
+6% +$62.5K 0.02% 802
2013
Q3 		$941K Buy
8,097
+417
+5% +$45.8K 0.02% 836
2013
Q2 		$709K Buy
+7,680
New +$740K 0.02% 908

Other funds holding ALXN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Placemark Investments's ALXN Position: Q4 2014 in Review

Placemark Investments reduced its Alexion Pharmaceuticals (ALXN) stake by 0.46% in Q4 2014, selling an estimated $10K and leaving 11,641 shares worth $2.15M. The position accounts for 0.04% of the portfolio, ranked #545.

Placemark Investments first reported a position in ALXN in Q2 2013 and has held it in 7 quarters since. 579 funds tracked by Wall St. Rank hold ALXN as of Q4 2014.

  • Placemark Investments held 11,641 shares of Alexion Pharmaceuticals worth $2.15M as of Q4 2014.
  • Placemark Investments sold 54 Alexion Pharmaceuticals shares in Q4 2014, an estimated $10K.
  • Alexion Pharmaceuticals made up 0.04% of Placemark Investments's portfolio in Q4 2014, its #545 holding.
  • Placemark Investments first reported a position in Alexion Pharmaceuticals in Q2 2013 and has held it in 7 quarters since.
  • 579 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q4 2014.

Based on Placemark Investments's 13F filing for Q4 2014, filed 17 Feb 2015.